L428 cells derived from Hodgkin's disease produce E Rosette-inhibiting factorKATAY, I; WIRNITZER, U; BURRICHTER, H et al.Blood. 1990, Vol 76, Num 4, pp 791-796, issn 0006-4971, 6 p.Conference Paper

Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dexa-BEAM)JOSTING, A; KATAY, I; RUEFFER, U et al.Annals of oncology. 1998, Vol 9, Num 3, pp 289-295, issn 0923-7534Article